$172.59
0.71% day before yesterday
NYSE, May 30, 10:10 pm CET
ISIN
US0758871091
Symbol
BDX

Becton, Dickinson & Stock price

$172.59
-34.50 16.66% 1M
-50.23 22.54% 6M
-54.28 23.93% YTD
-54.19 23.90% 1Y
-83.87 32.70% 3Y
-66.12 27.70% 5Y
+35.30 25.71% 10Y
NYSE, Closing price Fri, May 30 2025
-1.23 0.71%
ISIN
US0758871091
Symbol
BDX
Sector

Key metrics

Market capitalization $49.47b
Enterprise Value $68.05b
P/E (TTM) P/E ratio 32.75
EV/FCF (TTM) EV/FCF 26.27
EV/Sales (TTM) EV/Sales 3.26
P/S ratio (TTM) P/S ratio 2.37
P/B ratio (TTM) P/B ratio 1.96
Dividend yield 2.20%
Last dividend (FY24) $3.80
Revenue growth (TTM) Revenue growth 5.84%
Revenue (TTM) Revenue $20.87b
EBIT (operating result TTM) EBIT $2.73b
Free Cash Flow (TTM) Free Cash Flow $2.59b
Cash position $683.00m
EPS (TTM) EPS $5.27
P/E forward 34.66
P/S forward 2.27
EV/Sales forward 3.12
Short interest 1.14%
Show more

Is Becton, Dickinson & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Becton, Dickinson & Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

6x Buy
33%
12x Hold
67%

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

Buy
33%
Hold
67%

Financial data from Becton, Dickinson &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
20,867 20,867
6% 6%
100%
- Direct Costs 11,553 11,553
6% 6%
55%
9,314 9,314
6% 6%
45%
- Selling and Administrative Expenses 5,043 5,043
7% 7%
24%
- Research and Development Expense 1,246 1,246
6% 6%
6%
5,095 5,095
1% 1%
24%
- Depreciation and Amortization 2,369 2,369
3% 3%
11%
EBIT (Operating Income) EBIT 2,726 2,726
4% 4%
13%
Net Profit 1,519 1,519
15% 15%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Becton, Dickinson & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Becton, Dickinson & Stock News

Neutral
PRNewsWire
4 days ago
FRANKLIN LAKES, N.J. , May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data registry for the Rotarex™ Atherectomy System to measure real-world outcomes for patients with peripheral artery disease (PAD).
Positive
Seeking Alpha
5 days ago
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 2025 and the average growth rate at 4.75%. 22 Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.
Neutral
PRNewsWire
5 days ago
FRANKLIN LAKES, N.J. , May 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 2:00 pm Eastern Time.
More Becton, Dickinson & News

Company Profile

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Head office United States
CEO Thomas Polen
Employees 74,000
Founded 1897
Website www.bd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today